Shares of WuXi Biologics (Cayman) Inc. (OTCMKTS:WXXWY – Get Free Report) gapped up before the market opened on Friday . The stock had previously closed at $12.61, but opened at $13.3399. WuXi Biologics (Cayman) shares last traded at $13.3399, with a volume of 1,041 shares trading hands.
Analyst Upgrades and Downgrades
Separately, Zacks Research upgraded shares of WuXi Biologics (Cayman) to a “hold” rating in a research report on Friday, August 28th. One research analyst has rated the stock with a Hold rating, According to MarketBeat.com, the stock has an average rating of “Hold”.
Get Our Latest Stock Analysis on WXXWY
WuXi Biologics (Cayman) Price Performance
About WuXi Biologics (Cayman)
WuXi Biologics (Cayman) is a global contract research, development and manufacturing organization (CRDMO) focused on biologic medicines. The company provides integrated services to pharmaceutical and biotechnology customers across the development cycle, from early-stage discovery and preclinical research through clinical development, regulatory support and commercial manufacturing.
Its capabilities include the development and production of monoclonal antibodies, recombinant proteins, vaccines, antibody-drug conjugates and other biologic modalities.
See Also
- Five stocks we like better than WuXi Biologics (Cayman)
- These 3 Stocks Are Drawing Insider Buyers for Very Different Reasons
- Braze Beat Expectations—Now 2 SaaS Peers Are in Focus
- 3 Zero-Fee ETFs Worth More Than Their Cost
- 3 Nimble Free Cash Flow Names With Light Assets
Receive News & Ratings for WuXi Biologics (Cayman) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for WuXi Biologics (Cayman) and related companies with MarketBeat.com's FREE daily email newsletter.
